We applaud the actions our partners in global health, government, academia, and in the biotechnology industry are taking to end the devastating toll of COVID-19 on lives around the world. At Just – Evotec Biologics, we stand committed and are prepared to respond rapidly with our technology, resources, and expertise to the current and future pandemics when needed. Here is a summary of our capabilities.
Our technology and resources
Our Seattle-based capabilities include: antibody discovery, molecule optimization, cell line development, media optimization for high yield production for both antibodies and protein therapeutics. We can support toxicology fills as well as flexible cGMP manufacturing. Our upstream and downstream process development capabilities are unparalleled and we also provide comprehensive analytical support, and formulation development and optimization. In combination with our preferred vendor we offer fill/finish oversight.